Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease
Andrew P. Fontenot, … , Lee S. Newman, Brian L. Kotzin
Andrew P. Fontenot, … , Lee S. Newman, Brian L. Kotzin
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1473-1482. https://doi.org/10.1172/JCI15846.
View: Text | PDF
Article Aging

Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease

  • Text
  • PDF
Abstract

Research Article

Authors

Andrew P. Fontenot, Scott J. Canavera, Laia Gharavi, Lee S. Newman, Brian L. Kotzin

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Stimulation of BAL cells (a) and PBMCs (b) from the CBD patients. Prolif...
Stimulation of BAL cells (a) and PBMCs (b) from the CBD patients. Proliferation of the cells in medium alone and after the addition of 1 × 10–5 M BeSO4 is shown. Proliferation assays were performed with BAL cells from 8 of the 12 CBD patients and with PBMCs from 9 of the 12 patients. The stimulation index (SI) for each proliferative response is shown over the corresponding bar, and an SI indicative of a positive response is currently defined as ≥ 2.5. The data are expressed as the mean cpm ± SEM.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts